RxNews

Generics First -  Statin Program
In just the last year, high-quality statin generics that are able to provide up to 40% LDL-C lowering became available:

• simvastatin (Zocor^®)
• pravastatin (Pravachol^®)
• lovastatin (Mevacor^®)

New Generic Statins
These generic statins have proven track records, provide the best value, and can meet the needs of most patients in achieving their LDL-C goals.  These generic options  are most often available at a lower copayment than brand name statins, such as Crestor, Vytorin or Lipitor.  These lower out-of-pocket expenses may help patients adhere to their medication therapy.

Prior Authorization of Brand Name Statins
Because of the several generic options available, Regence will begin prior authorization of new prescriptions for brand name statins below.   Members already on a brand name statin do not need prior authorization.   

If Your Patient Needs Prior Authorization

• Please consider a generic statin option.  Prescribing a generic statin will avoid the prior authorization process and may lower the patient’s copayment.
• If a generic statin is not able to provide adequate LDL lowering (i.e., the patient needs more than 40% LDL-C lowering), prior authorization is needed for Crestor, Vytorin, and Lipitor.  (The patient’s current LDL level and LDL goal are needed as part of the request).
  • Crestor or Vytorin are the preferred brand statins authorized for coverage.
  • Lipitor may be authorized when Crestor and Vytorin are not options
• The medication policy for the statin medications can be accessed on our website at:
  www.regencerx.com/learn/policy/index.html
• For a copy of the form to request a prior authorization, please see: www.regencerx.com/docs/forms/priorAuth/priorAuthorization.pdf